Resources

A study on funding for malaria research and development (R&D) has identified the tracking of support for research for implementation as a particular challenge. Developed by a consortium of research and development organizations, the report highlights gaps in financial reporting and monitoring tools to document funding in this area.   The preview report, published on April 16, draws on a longer analysis developed by Malaria No More UK, PATH, and the Special Programme for Research and Training in Tropical Diseases (TDR) based at the World Health Organization (WHO), together with the Foundation for Innovative New Diagnostics, Innovative Vector Control Consortium, Medicines for Malaria Venture, Policy Cures Research, and WHO’s Global Malaria Programme.

This factsheet describes PATH's work, in collaboration with MSR® Global Health, to develop the SafiStationTM Chlorine Generator, an innovative onsite chlorine generator for drinking water treatment and infection prevention and control. This technology was previously known as the SE Flow Chlorine Generator.

This fact sheet outlines PATH's pneumococcal vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio and partners to support the development of vaccines against pneumonia and other pneumococcal diseases that can be effective and affordable for children in the developing world.

During the early years of life, growth faltering due to undernutrition has both immediate and lifelong consequences for human health and development. In this brief, we examine systematic reviews and meta-analyses that investigate the impacts of selected underlying, nutrition-sensitive risk factors on stunted linear growth.

Market assessment and recommendations to increase access to oxygen and pulse oximetry in Indonesia